Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups
Launched by BOSTON MEDICAL CENTER · Oct 10, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Vaccine Confidence Study is looking into how to boost trust in vaccines among marginalized racial and ethnic groups, specifically focusing on the MMR (measles, mumps, and rubella) and RSV (respiratory syncytial virus) vaccines during pregnancy and early childhood. These vaccines are important because they help prevent serious illnesses and hospital visits. The study aims to understand the reasons behind vaccine hesitancy and refusal by talking to parents of young children, healthcare workers, and experts in vaccine confidence.
If you're a parent of a child aged 12 to 24 months who receives care at Boston Medical Center, you might be eligible to participate in this study. Eligible participants include birthing parents of any age who are comfortable speaking English, Spanish, or Haitian Creole and who were pregnant during the RSV season (October to February). Participants will be interviewed about their views on vaccines, which can help improve vaccination efforts in the future. Your input could make a big difference in understanding how to encourage more people to get vaccinated.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parent and child-
- • The birthing parent of any age of a child (aged 12-24 months) who receives primary care at Boston Medical Center
- • A birthing parent who is registered as a patient at Boston Medical Center
- • The birthing parent must have been pregnant between the months of October and February (RSV season)
- • The birthing parent must be comfortable completing an interview in English, Spanish, or Haitian Creole.
- • Clinician
- • Clinical provider (including Community Health Workers, Physicians, Physician Assistants and Nurse Practitioners) aged 18+ years at Boston Medical Center within Pediatrics, Family Medicine, or OB/GYN. These clinicians will have been involved in past or current successful vaccine-specific Evidence Based Interventions (EBI) beyond BMC and its affiliated Community Health Center (CHC).
- • EBI Expert
- • Content experts (aged 18+ years) in the areas of Implementation Science, Vaccine-specific EBIs, and Prenatal genetic counseling
- Exclusion Criteria:
- • Clinical provider (including Community Health Workers, Physicians, Physician Assistants and Nurse Practitioners) at NON-BMC clinic/Community Health Center
- • Content experts - NON-Vaccine evidence based interventions (EBIs)
About Boston Medical Center
Boston Medical Center (BMC) is a leading academic medical center located in Boston, Massachusetts, dedicated to providing high-quality, compassionate care to diverse populations. As a prominent clinical trial sponsor, BMC conducts innovative research aimed at advancing medical knowledge and improving patient outcomes across a wide range of specialties. With a commitment to health equity and access to care, BMC collaborates with various stakeholders, including academic institutions and industry partners, to facilitate groundbreaking studies and translate findings into effective treatments. Its robust infrastructure and experienced research teams ensure adherence to the highest ethical standards and regulatory compliance in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Michelle Stransky, PhD
Principal Investigator
Boston Medical Center, Pediatrics
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported